Pharmacotherapy for incident attention-deficit/hyperactivity disorder: practice patterns and quality metrics
Regina Bussing(University of Florida), Matthew F. Daley(Kaiser Permanente), Lisa J. Herrinton(Kaiser Permanente), Joseph A. Boscarino(Ramapo College), Pamala A. Pawloski(HealthPartners), Almut G. Winterstein(University of Florida), James D. Nordin(HealthPartners), Sengwee Toh(Harvard University), Komal J. Narwaney(Kaiser Permanente), Dana M. Mason(University of Florida), Douglas Newton(Kaiser Permanente), Lynn DeBar(Group Health Cooperative)
Cited by 11
Related Papers
Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration — United States, 2020
|MMWR Morbidity and Mortality Weekly Report|2020|720
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
|MMWR Morbidity and Mortality Weekly Report|2021|602
Human Papillomavirus Vaccination Practices: A Survey of US Physicians 18 Months After Licensure
|PEDIATRICS|2010|242
Monitoring the safety of quadrivalent human papillomavirus vaccine: Findings from the Vaccine Safety Datalink
|Vaccine|2011|228
Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021
|MMWR Morbidity and Mortality Weekly Report|2021|216